JP2014210813A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014210813A5 JP2014210813A5 JP2014162039A JP2014162039A JP2014210813A5 JP 2014210813 A5 JP2014210813 A5 JP 2014210813A5 JP 2014162039 A JP2014162039 A JP 2014162039A JP 2014162039 A JP2014162039 A JP 2014162039A JP 2014210813 A5 JP2014210813 A5 JP 2014210813A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- blending ratio
- eye drop
- contact lens
- silicone hydrogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims 8
- 239000003889 eye drop Substances 0.000 claims 8
- 238000002156 mixing Methods 0.000 claims 8
- 239000000017 hydrogel Substances 0.000 claims 6
- 229920001296 polysiloxane Polymers 0.000 claims 6
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims 4
- 229960000458 allantoin Drugs 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 239000002736 nonionic surfactant Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 208000028006 Corneal injury Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 230000000172 allergic effect Effects 0.000 claims 2
- 208000010668 atopic eczema Diseases 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 230000003449 preventive effect Effects 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 230000010065 bacterial adhesion Effects 0.000 claims 1
- 230000035699 permeability Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014162039A JP5700479B2 (ja) | 2009-02-19 | 2014-08-08 | シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009037243 | 2009-02-19 | ||
| JP2009037243 | 2009-02-19 | ||
| JP2014162039A JP5700479B2 (ja) | 2009-02-19 | 2014-08-08 | シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009112176A Division JP5632589B2 (ja) | 2009-02-19 | 2009-05-01 | シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015023916A Division JP2015091887A (ja) | 2009-02-19 | 2015-02-10 | シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014210813A JP2014210813A (ja) | 2014-11-13 |
| JP2014210813A5 true JP2014210813A5 (enExample) | 2014-12-25 |
| JP5700479B2 JP5700479B2 (ja) | 2015-04-15 |
Family
ID=42974836
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009112176A Active JP5632589B2 (ja) | 2009-02-19 | 2009-05-01 | シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
| JP2014162039A Active JP5700479B2 (ja) | 2009-02-19 | 2014-08-08 | シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
| JP2015023916A Withdrawn JP2015091887A (ja) | 2009-02-19 | 2015-02-10 | シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009112176A Active JP5632589B2 (ja) | 2009-02-19 | 2009-05-01 | シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015023916A Withdrawn JP2015091887A (ja) | 2009-02-19 | 2015-02-10 | シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (3) | JP5632589B2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5632589B2 (ja) * | 2009-02-19 | 2014-11-26 | ロート製薬株式会社 | シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
| JP6333023B2 (ja) * | 2014-03-31 | 2018-05-30 | 小林製薬株式会社 | 水性医薬組成物 |
| JP6313456B2 (ja) * | 2015-09-30 | 2018-04-18 | 株式会社メニコン | コンタクトレンズパッケージ及びその製造方法 |
| JP7598699B2 (ja) * | 2017-06-01 | 2024-12-12 | ロート製薬株式会社 | 視覚機能の再活性化用眼科組成物 |
| JP2022099576A (ja) * | 2020-12-23 | 2022-07-05 | 小林製薬株式会社 | 点眼型洗眼用組成物 |
| JP2022099575A (ja) * | 2020-12-23 | 2022-07-05 | 小林製薬株式会社 | 洗眼用組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH085970A (ja) * | 1994-06-21 | 1996-01-12 | Hoya Corp | ソフトコンタクトレンズ用剤 |
| JP2000347142A (ja) * | 1999-06-02 | 2000-12-15 | Tomey Corp | コンタクトレンズ用洗浄・保存液剤 |
| JP4890829B2 (ja) * | 2005-09-30 | 2012-03-07 | ロート製薬株式会社 | アズレン含有水性液剤 |
| JP4907388B2 (ja) * | 2006-02-28 | 2012-03-28 | ロート製薬株式会社 | コンタクトレンズ用眼科組成物 |
| JP2008024700A (ja) * | 2006-06-23 | 2008-02-07 | Rohto Pharmaceut Co Ltd | ベルベリン含有水性組成物 |
| JP5632589B2 (ja) * | 2009-02-19 | 2014-11-26 | ロート製薬株式会社 | シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
-
2009
- 2009-05-01 JP JP2009112176A patent/JP5632589B2/ja active Active
-
2014
- 2014-08-08 JP JP2014162039A patent/JP5700479B2/ja active Active
-
2015
- 2015-02-10 JP JP2015023916A patent/JP2015091887A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014210813A5 (enExample) | ||
| WO2018026722A8 (en) | COMPOSITIONS AND METHODS FOR INHIBITING MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS | |
| JP2014211652A5 (enExample) | ||
| JP2013006877A5 (enExample) | ||
| EP2996172A3 (en) | Biocompatibility of biomedical energization elements | |
| IL268160A (en) | Anti-TNF antibodies, preparations and methods for the treatment of active ankylosing spondylitis | |
| EP3137116A4 (en) | Dendrimer compositions and their use in treatment of diseases of the eye | |
| EP3142664A4 (en) | Compositions and methods for treating and diagnosing ocular disorders | |
| HK1252037A1 (zh) | 治疗炎性疾病的方法 | |
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| EP3651747A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT OF EYE DISORDERS | |
| WO2016094834A3 (en) | A method for treating a complement mediated disorder caused by an infectious agent in a patient | |
| WO2016079110A3 (en) | Use of enzyme for cleaning | |
| PH12017500615A1 (en) | Ophthalmic composition comprising cyclosporine and trehalose | |
| WO2016001885A3 (en) | Amorphous form of eliglustat hemitartarate | |
| EP3310353A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF EYE DISEASES | |
| WO2015080980A3 (en) | Treatment of autoimmune and/or inflammatory disease using novel caveolin modulators | |
| JP2011132227A5 (enExample) | ||
| JP2014210807A5 (enExample) | ||
| JP2018500094A5 (enExample) | ||
| PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
| WO2016015055A8 (en) | Colon cleansing compositions | |
| FR3018045B1 (fr) | Composition ophtalmique remanente, notamment pour le traitement de la secheresse oculaire | |
| JP2014205716A5 (enExample) | ||
| WO2017129577A8 (en) | Ophthalmic gabapentin for the treatment of corneal ulcers |